CA3079553A1 - Compositions and methods for treating age-related macular degeneration - Google Patents

Info

Publication number

CA3079553A1

CA3079553A1 CA3079553A CA3079553A CA3079553A1 CA 3079553 A1 CA3079553 A1 CA 3079553A1 CA 3079553 A CA3079553 A CA 3079553A CA 3079553 A CA3079553 A CA 3079553A CA 3079553 A1 CA3079553 A1 CA 3079553A1

Authority

CA

Canada

Prior art keywords

vector

promoter

cfh

aav

seq

Prior art date

2017-10-20

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 108
• 239000000203 mixture Substances 0.000 title claims abstract description 84
• 208000002780 macular degeneration Diseases 0.000 title claims description 45
• 206010064930 age-related macular degeneration Diseases 0.000 title claims description 43
• 239000013598 vector Substances 0.000 claims abstract description 286
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 196
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 34
• 210000004027 cell Anatomy 0.000 claims description 238
• 108010053085 Complement Factor H Proteins 0.000 claims description 209
• 239000012634 fragment Substances 0.000 claims description 141
• 125000003729 nucleotide group Chemical group 0.000 claims description 141
• 239000002773 nucleotide Substances 0.000 claims description 139
• 230000014509 gene expression Effects 0.000 claims description 105
• 102000004169 proteins and genes Human genes 0.000 claims description 95
• 239000013607 AAV vector Substances 0.000 claims description 81
• 102000040430 polynucleotide Human genes 0.000 claims description 39
• 108091033319 polynucleotide Proteins 0.000 claims description 39
• 239000002157 polynucleotide Substances 0.000 claims description 39
• 210000003583 retinal pigment epithelium Anatomy 0.000 claims description 35
• 230000035772 mutation Effects 0.000 claims description 29
• 210000001525 retina Anatomy 0.000 claims description 27
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 24
• 230000003612 virological effect Effects 0.000 claims description 24
• 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 23
• 230000008488 polyadenylation Effects 0.000 claims description 23
• 230000000694 effects Effects 0.000 claims description 15
• 208000035913 Atypical hemolytic uremic syndrome Diseases 0.000 claims description 10
• 101000737574 Homo sapiens Complement factor H Proteins 0.000 claims description 9
• 239000003937 drug carrier Substances 0.000 claims description 9
• 230000001939 inductive effect Effects 0.000 claims description 9
• 208000003098 Ganglion Cysts Diseases 0.000 claims description 8
• 208000005400 Synovial Cyst Diseases 0.000 claims description 8
• 102000045512 human CFH Human genes 0.000 claims description 8
• 208000017169 kidney disease Diseases 0.000 claims description 8
• 210000005229 liver cell Anatomy 0.000 claims description 8
• 239000003550 marker Substances 0.000 claims description 8
• 239000012528 membrane Substances 0.000 claims description 8
• 102100035431 Complement factor I Human genes 0.000 claims description 7
• 206010025421 Macule Diseases 0.000 claims description 7
• 230000000670 limiting effect Effects 0.000 claims description 7
• 210000004379 membrane Anatomy 0.000 claims description 7
• 101150030967 CFH gene Proteins 0.000 claims description 6
• 108091005804 Peptidases Proteins 0.000 claims description 6
• 239000004365 Protease Substances 0.000 claims description 6
• 230000004777 loss-of-function mutation Effects 0.000 claims description 6
• 101150091459 CFI gene Proteins 0.000 claims description 5
• 108090001126 Furin Proteins 0.000 claims description 5
• 230000024203 complement activation Effects 0.000 claims description 5
• 102200031620 rs121964917 Human genes 0.000 claims description 5
• 102200031623 rs182078921 Human genes 0.000 claims description 5
• 102220044450 rs199749372 Human genes 0.000 claims description 5
• 102220061985 rs777491912 Human genes 0.000 claims description 5
• 102220018846 rs80358505 Human genes 0.000 claims description 5
• 102220599936 Disks large-associated protein 5_G69E_mutation Human genes 0.000 claims description 4
• 102200024937 c.1016G>A Human genes 0.000 claims description 4
• 230000015556 catabolic process Effects 0.000 claims description 4
• 210000004185 liver Anatomy 0.000 claims description 4
• 102220145638 rs113460688 Human genes 0.000 claims description 4
• 102200027734 rs118092776 Human genes 0.000 claims description 4
• 102200031710 rs121913059 Human genes 0.000 claims description 4
• 102200031950 rs121913062 Human genes 0.000 claims description 4
• 102220258161 rs140380494 Human genes 0.000 claims description 4
• 102220130078 rs143237092 Human genes 0.000 claims description 4
• 102220011552 rs397514673 Human genes 0.000 claims description 4
• 102220047868 rs570523689 Human genes 0.000 claims description 4
• 102220048835 rs75741316 Human genes 0.000 claims description 4
• 210000001775 bruch membrane Anatomy 0.000 claims description 3
• 210000004899 c-terminal region Anatomy 0.000 claims description 3
• 210000004126 nerve fiber Anatomy 0.000 claims description 3
• 102200007423 rs121965030 Human genes 0.000 claims description 3
• 102200031639 rs141853578 Human genes 0.000 claims description 3
• 102200037607 rs771019366 Human genes 0.000 claims description 3
• 210000002987 choroid plexus Anatomy 0.000 claims description 2
• 102200036652 rs121434424 Human genes 0.000 claims description 2
• 102220253124 rs1555937166 Human genes 0.000 claims description 2
• 102220226669 rs367677199 Human genes 0.000 claims description 2
• 102100035432 Complement factor H Human genes 0.000 claims 23
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
• 102100021244 Integral membrane protein GPR180 Human genes 0.000 claims 1
• 102220612381 Mitogen-activated protein kinase kinase kinase 1_S58A_mutation Human genes 0.000 claims 1
• 102200147378 rs398123072 Human genes 0.000 claims 1
• 230000004154 complement system Effects 0.000 abstract description 40
• 201000010099 disease Diseases 0.000 abstract description 29
• 101710127220 Four and a half LIM domains protein 1 Proteins 0.000 abstract description 20
• 102100038651 Four and a half LIM domains protein 1 Human genes 0.000 abstract description 20
• 241000702421 Dependoparvovirus Species 0.000 abstract description 10
• 230000002401 inhibitory effect Effects 0.000 abstract description 3
• 102000016550 Complement Factor H Human genes 0.000 description 187
• 235000018102 proteins Nutrition 0.000 description 92
• 108700019146 Transgenes Proteins 0.000 description 79
• 235000001014 amino acid Nutrition 0.000 description 66
• 108090000765 processed proteins & peptides Proteins 0.000 description 64
• 210000001508 eye Anatomy 0.000 description 63
• 102000004196 processed proteins & peptides Human genes 0.000 description 61
• 229940024606 amino acid Drugs 0.000 description 60
• 229920001184 polypeptide Polymers 0.000 description 58
• 150000001413 amino acids Chemical class 0.000 description 54
• 150000007523 nucleic acids Chemical class 0.000 description 50
• 239000013608 rAAV vector Substances 0.000 description 41
• 102100040132 Complement factor H-related protein 1 Human genes 0.000 description 40
• 101000890732 Homo sapiens Complement factor H-related protein 1 Proteins 0.000 description 40
• 230000006870 function Effects 0.000 description 40
• -1 and/or their analogs Substances 0.000 description 37
• 239000002245 particle Substances 0.000 description 35
• 102000039446 nucleic acids Human genes 0.000 description 33
• 108020004707 nucleic acids Proteins 0.000 description 33
• 238000004519 manufacturing process Methods 0.000 description 32
• 238000002347 injection Methods 0.000 description 28
• 239000007924 injection Substances 0.000 description 28
• 210000000234 capsid Anatomy 0.000 description 25
• 108091008695 photoreceptors Proteins 0.000 description 25
• 238000002560 therapeutic procedure Methods 0.000 description 25
• 108020004414 DNA Proteins 0.000 description 23
• 108091028043 Nucleic acid sequence Proteins 0.000 description 23
• 102100035326 Complement factor H-related protein 2 Human genes 0.000 description 22
• 102100035321 Complement factor H-related protein 3 Human genes 0.000 description 22
• 102100035324 Complement factor H-related protein 4 Human genes 0.000 description 22
• 102100035325 Complement factor H-related protein 5 Human genes 0.000 description 22
• 101000878135 Homo sapiens Complement factor H-related protein 2 Proteins 0.000 description 22
• 101000878136 Homo sapiens Complement factor H-related protein 3 Proteins 0.000 description 22
• 101000878133 Homo sapiens Complement factor H-related protein 4 Proteins 0.000 description 22
• 101000878134 Homo sapiens Complement factor H-related protein 5 Proteins 0.000 description 22
• 238000011282 treatment Methods 0.000 description 22
• 241000700605 Viruses Species 0.000 description 21
• 238000004806 packaging method and process Methods 0.000 description 21
• 239000008194 pharmaceutical composition Substances 0.000 description 20
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 19
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
• 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 17
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 17
• 229960000723 ampicillin Drugs 0.000 description 17
• 239000013612 plasmid Substances 0.000 description 17
• 210000001519 tissue Anatomy 0.000 description 17
• 230000001105 regulatory effect Effects 0.000 description 16
• 239000013643 reference control Substances 0.000 description 15
• 238000012360 testing method Methods 0.000 description 15
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 14
• 108090000565 Capsid Proteins Proteins 0.000 description 14
• 102100023321 Ceruloplasmin Human genes 0.000 description 14
• 238000012217 deletion Methods 0.000 description 14
• 230000037430 deletion Effects 0.000 description 14
• 239000000243 solution Substances 0.000 description 14
• 102100028001 Retinaldehyde-binding protein 1 Human genes 0.000 description 13
• 230000000295 complement effect Effects 0.000 description 13
• 239000003814 drug Substances 0.000 description 13
• 229920002451 polyvinyl alcohol Polymers 0.000 description 13
• 239000000047 product Substances 0.000 description 13
• 238000006467 substitution reaction Methods 0.000 description 13
• 241000701161 unidentified adenovirus Species 0.000 description 13
• 238000001262 western blot Methods 0.000 description 13
• 101001078886 Homo sapiens Retinaldehyde-binding protein 1 Proteins 0.000 description 11
• 239000003623 enhancer Substances 0.000 description 11
• 101000734572 Homo sapiens Phosphoenolpyruvate carboxykinase, cytosolic [GTP] Proteins 0.000 description 10
• 102100034796 Phosphoenolpyruvate carboxykinase, cytosolic [GTP] Human genes 0.000 description 10
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 9
• 241000125945 Protoparvovirus Species 0.000 description 9
• 238000001415 gene therapy Methods 0.000 description 9
• 239000002953 phosphate buffered saline Substances 0.000 description 9
• 230000000069 prophylactic effect Effects 0.000 description 9
• 235000020945 retinal Nutrition 0.000 description 9
• 239000011604 retinal Substances 0.000 description 9
• 230000002207 retinal effect Effects 0.000 description 9
• 239000011780 sodium chloride Substances 0.000 description 9
• 241000894007 species Species 0.000 description 9
• NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 9
• 241001655883 Adeno-associated virus - 1 Species 0.000 description 8
• 241001164825 Adeno-associated virus - 8 Species 0.000 description 8
• 102100027211 Albumin Human genes 0.000 description 8
• 201000004569 Blindness Diseases 0.000 description 8
• 101710163595 Chaperone protein DnaK Proteins 0.000 description 8
• 241000701022 Cytomegalovirus Species 0.000 description 8
• 102000053602 DNA Human genes 0.000 description 8
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 8
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 8
• 101710178376 Heat shock 70 kDa protein Proteins 0.000 description 8
• 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 description 8
• 101000693913 Homo sapiens Albumin Proteins 0.000 description 8
• 108091034117 Oligonucleotide Proteins 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• 230000002068 genetic effect Effects 0.000 description 8
• 239000005090 green fluorescent protein Substances 0.000 description 8
• 238000003780 insertion Methods 0.000 description 8
• 230000037431 insertion Effects 0.000 description 8
• 230000004048 modification Effects 0.000 description 8
• 238000012986 modification Methods 0.000 description 8
• 230000010076 replication Effects 0.000 description 8
• 125000006850 spacer group Chemical group 0.000 description 8
• 239000013603 viral vector Substances 0.000 description 8
• 241000580270 Adeno-associated virus - 4 Species 0.000 description 7
• 241001634120 Adeno-associated virus - 5 Species 0.000 description 7
• 108010069112 Complement System Proteins Proteins 0.000 description 7
• 241001465754 Metazoa Species 0.000 description 7
• 241000699666 Mus <mouse, genus> Species 0.000 description 7
• 238000007792 addition Methods 0.000 description 7
• 239000000872 buffer Substances 0.000 description 7
• 235000000346 sugar Nutrition 0.000 description 7
• 229940124597 therapeutic agent Drugs 0.000 description 7
• 230000001225 therapeutic effect Effects 0.000 description 7
• 238000005406 washing Methods 0.000 description 7
• 241000202702 Adeno-associated virus - 3 Species 0.000 description 6
• 241000972680 Adeno-associated virus - 6 Species 0.000 description 6
• 241001164823 Adeno-associated virus - 7 Species 0.000 description 6
• 241000649045 Adeno-associated virus 10 Species 0.000 description 6
• 102000000989 Complement System Proteins Human genes 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 241000283973 Oryctolagus cuniculus Species 0.000 description 6
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 6
• 230000004438 eyesight Effects 0.000 description 6
• 208000015181 infectious disease Diseases 0.000 description 6
• 108020004999 messenger RNA Proteins 0.000 description 6
• 210000000608 photoreceptor cell Anatomy 0.000 description 6
• 238000012545 processing Methods 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• 238000013518 transcription Methods 0.000 description 6
• 230000035897 transcription Effects 0.000 description 6
• 230000004393 visual impairment Effects 0.000 description 6
• 241000649046 Adeno-associated virus 11 Species 0.000 description 5
• 241000649047 Adeno-associated virus 12 Species 0.000 description 5
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 5
• 208000022873 Ocular disease Diseases 0.000 description 5
• 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 5
• 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 5
• 108010029485 Protein Isoforms Proteins 0.000 description 5
• 102000001708 Protein Isoforms Human genes 0.000 description 5
• 239000000969 carrier Substances 0.000 description 5
• 230000003247 decreasing effect Effects 0.000 description 5
• 238000010790 dilution Methods 0.000 description 5
• 239000012895 dilution Substances 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 239000007788 liquid Substances 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 210000002569 neuron Anatomy 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 239000001509 sodium citrate Substances 0.000 description 5
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
• 238000010561 standard procedure Methods 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 230000008685 targeting Effects 0.000 description 5
• 238000001890 transfection Methods 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• 230000004304 visual acuity Effects 0.000 description 5
• 108700028369 Alleles Proteins 0.000 description 4
• 241000283690 Bos taurus Species 0.000 description 4
• 108090000994 Catalytic RNA Proteins 0.000 description 4
• 102000053642 Catalytic RNA Human genes 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 4
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 4
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
• 102100038300 Metabotropic glutamate receptor 6 Human genes 0.000 description 4
• 102000035195 Peptidases Human genes 0.000 description 4
• 206010038848 Retinal detachment Diseases 0.000 description 4
• 208000017442 Retinal disease Diseases 0.000 description 4
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
• 230000002378 acidificating effect Effects 0.000 description 4
• 230000003444 anaesthetic effect Effects 0.000 description 4
• UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
• 238000004113 cell culture Methods 0.000 description 4
• 239000000356 contaminant Substances 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 208000035475 disorder Diseases 0.000 description 4
• 238000002571 electroretinography Methods 0.000 description 4
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 4
• 238000003306 harvesting Methods 0.000 description 4
• 210000002287 horizontal cell Anatomy 0.000 description 4
• 238000009396 hybridization Methods 0.000 description 4
• 238000003384 imaging method Methods 0.000 description 4
• 238000011068 loading method Methods 0.000 description 4
• 108010038450 metabotropic glutamate receptor 6 Proteins 0.000 description 4
• 238000010369 molecular cloning Methods 0.000 description 4
• 210000004498 neuroglial cell Anatomy 0.000 description 4
• 229920001983 poloxamer Polymers 0.000 description 4
• 230000002265 prevention Effects 0.000 description 4
• 230000001179 pupillary effect Effects 0.000 description 4
• 108010054624 red fluorescent protein Proteins 0.000 description 4
• 101150066583 rep gene Proteins 0.000 description 4
• 108091092562 ribozyme Proteins 0.000 description 4
• FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
• 210000002966 serum Anatomy 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• 210000002845 virion Anatomy 0.000 description 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
• 241000283707 Capra Species 0.000 description 3
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 3
• 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 3
• 102100031614 Ciliary neurotrophic factor Human genes 0.000 description 3
• 108020004705 Codon Proteins 0.000 description 3
• 102220593374 Complement factor H_R567G_mutation Human genes 0.000 description 3
• 102000004961 Furin Human genes 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• 101000597428 Homo sapiens Nucleoredoxin-like protein 1 Proteins 0.000 description 3
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 3
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 3
• 201000003533 Leber congenital amaurosis Diseases 0.000 description 3
• 241000699670 Mus sp. Species 0.000 description 3
• 102100035399 Nucleoredoxin-like protein 1 Human genes 0.000 description 3
• 102000010175 Opsin Human genes 0.000 description 3
• 108050001704 Opsin Proteins 0.000 description 3
• 201000007737 Retinal degeneration Diseases 0.000 description 3
• 108010034546 Serratia marcescens nuclease Proteins 0.000 description 3
• 108020004682 Single-Stranded DNA Proteins 0.000 description 3
• 210000000411 amacrine cell Anatomy 0.000 description 3
• 125000000539 amino acid group Chemical group 0.000 description 3
• 238000004458 analytical method Methods 0.000 description 3
• 125000003118 aryl group Chemical group 0.000 description 3
• 238000003556 assay Methods 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000000903 blocking effect Effects 0.000 description 3
• 229910052796 boron Inorganic materials 0.000 description 3
• 239000011575 calcium Substances 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 230000004456 color vision Effects 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 230000007812 deficiency Effects 0.000 description 3
• 230000007850 degeneration Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 230000010339 dilation Effects 0.000 description 3
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 238000001914 filtration Methods 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 239000000499 gel Substances 0.000 description 3
• 229960002591 hydroxyproline Drugs 0.000 description 3
• 238000003364 immunohistochemistry Methods 0.000 description 3
• 239000012535 impurity Substances 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 230000002458 infectious effect Effects 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 229910052751 metal Inorganic materials 0.000 description 3
• 239000002184 metal Substances 0.000 description 3
• 150000002739 metals Chemical class 0.000 description 3
• 238000012014 optical coherence tomography Methods 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 238000010188 recombinant method Methods 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 230000004258 retinal degeneration Effects 0.000 description 3
• 230000004264 retinal detachment Effects 0.000 description 3
• 210000003994 retinal ganglion cell Anatomy 0.000 description 3
• 239000000790 retinal pigment Substances 0.000 description 3
• 102200022582 rs120074176 Human genes 0.000 description 3
• 102220066169 rs149678971 Human genes 0.000 description 3
• 102200035611 rs1535692 Human genes 0.000 description 3
• 102220238245 rs1555952639 Human genes 0.000 description 3
• 102220034802 rs199475619 Human genes 0.000 description 3
• 102220059238 rs748417604 Human genes 0.000 description 3
• 102200076833 rs869312133 Human genes 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 230000035945 sensitivity Effects 0.000 description 3
• 230000001954 sterilising effect Effects 0.000 description 3
• 150000008163 sugars Chemical class 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 230000008719 thickening Effects 0.000 description 3
• 238000003151 transfection method Methods 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• JEOQACOXAOEPLX-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;1,3-thiazolidine-4-carboxylic acid Chemical compound OC(=O)C1CSCN1.OC(=O)[C@@H](N)CCCN=C(N)N JEOQACOXAOEPLX-WCCKRBBISA-N 0.000 description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
• FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 102100022002 CD59 glycoprotein Human genes 0.000 description 2
• 101150044789 Cap gene Proteins 0.000 description 2
• 102100031191 Cilia- and flagella-associated protein 91 Human genes 0.000 description 2
• 108091062157 Cis-regulatory element Proteins 0.000 description 2
• 108010078015 Complement C3b Proteins 0.000 description 2
• 102100025680 Complement decay-accelerating factor Human genes 0.000 description 2
• 102220593356 Complement factor H_E850K_mutation Human genes 0.000 description 2
• 102220580077 Complement factor H_W1183L_mutation Human genes 0.000 description 2
• 102220592822 Complement factor H_Y402H_mutation Human genes 0.000 description 2
• 102220593298 Complement factor H_Y951H_mutation Human genes 0.000 description 2
• 102220580069 Complement factor I_P64L_mutation Human genes 0.000 description 2
• 108091035707 Consensus sequence Proteins 0.000 description 2
• 230000004543 DNA replication Effects 0.000 description 2
• 206010012689 Diabetic retinopathy Diseases 0.000 description 2
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
• 102100037024 E3 ubiquitin-protein ligase XIAP Human genes 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 241000991587 Enterovirus C Species 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• 241000283074 Equus asinus Species 0.000 description 2
• 101000823089 Equus caballus Alpha-1-antiproteinase 1 Proteins 0.000 description 2
• 208000036357 GUCY2D-related recessive retinopathy Diseases 0.000 description 2
• 241000287828 Gallus gallus Species 0.000 description 2
• 208000010412 Glaucoma Diseases 0.000 description 2
• 101150102661 HIR1 gene Proteins 0.000 description 2
• 102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 description 2
• 108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 description 2
• 101710154606 Hemagglutinin Proteins 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 2
• 101000776592 Homo sapiens Cilia- and flagella-associated protein 91 Proteins 0.000 description 2
• 101000856022 Homo sapiens Complement decay-accelerating factor Proteins 0.000 description 2
• 101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 description 2
• 101000729271 Homo sapiens Retinoid isomerohydrolase Proteins 0.000 description 2
• 108091006905 Human Serum Albumin Proteins 0.000 description 2
• 102000008100 Human Serum Albumin Human genes 0.000 description 2
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
• 108060001084 Luciferase Proteins 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 102100039373 Membrane cofactor protein Human genes 0.000 description 2
• 101000597433 Mus musculus Nucleoredoxin-like protein 1 Proteins 0.000 description 2
• KSPIYJQBLVDRRI-UHFFFAOYSA-N N-methylisoleucine Chemical compound CCC(C)C(NC)C(O)=O KSPIYJQBLVDRRI-UHFFFAOYSA-N 0.000 description 2
• 102220486726 Neuropeptide S receptor_I578T_mutation Human genes 0.000 description 2
• 102100036205 Nucleoredoxin-like protein 2 Human genes 0.000 description 2
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
• 102100035846 Pigment epithelium-derived factor Human genes 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 101710176177 Protein A56 Proteins 0.000 description 2
• 102100029812 Protein S100-A12 Human genes 0.000 description 2
• 101710110949 Protein S100-A12 Proteins 0.000 description 2
• 102220468074 Putative tripartite motif-containing protein 49B_Y369S_mutation Human genes 0.000 description 2
• 102100022663 Retinal guanylyl cyclase 1 Human genes 0.000 description 2
• 206010057430 Retinal injury Diseases 0.000 description 2
• 101710101931 Retinaldehyde-binding protein 1 Proteins 0.000 description 2
• 102100031176 Retinoid isomerohydrolase Human genes 0.000 description 2
• 102100038247 Retinol-binding protein 3 Human genes 0.000 description 2
• 206010038923 Retinopathy Diseases 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• 108010077895 Sarcosine Proteins 0.000 description 2
• 101100506779 Schizosaccharomyces pombe (strain 972 / ATCC 24843) hip1 gene Proteins 0.000 description 2
• 102000012479 Serine Proteases Human genes 0.000 description 2
• 108010022999 Serine Proteases Proteins 0.000 description 2
• 108091027967 Small hairpin RNA Proteins 0.000 description 2
• 241001492404 Woodchuck hepatitis virus Species 0.000 description 2
• 108700031544 X-Linked Inhibitor of Apoptosis Proteins 0.000 description 2
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 230000003321 amplification Effects 0.000 description 2
• 125000000129 anionic group Chemical group 0.000 description 2
• 230000000692 anti-sense effect Effects 0.000 description 2
• 230000003416 augmentation Effects 0.000 description 2
• 230000033228 biological regulation Effects 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 102220363141 c.1624G>A Human genes 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 210000003161 choroid Anatomy 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 201000006754 cone-rod dystrophy Diseases 0.000 description 2
• 230000021615 conjugation Effects 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 238000009295 crossflow filtration Methods 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 230000008021 deposition Effects 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 230000007717 exclusion Effects 0.000 description 2
• 210000000720 eyelash Anatomy 0.000 description 2
• 210000000744 eyelid Anatomy 0.000 description 2
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
• 230000009368 gene silencing by RNA Effects 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 125000005647 linker group Chemical group 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 238000013507 mapping Methods 0.000 description 2
• 239000012092 media component Substances 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 238000000386 microscopy Methods 0.000 description 2
• 230000007935 neutral effect Effects 0.000 description 2
• 238000003199 nucleic acid amplification method Methods 0.000 description 2
• 238000002577 ophthalmoscopy Methods 0.000 description 2
• 230000005043 peripheral vision Effects 0.000 description 2
• 108090000102 pigment epithelium-derived factor Proteins 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 230000001124 posttranscriptional effect Effects 0.000 description 2
• 230000008569 process Effects 0.000 description 2
• 125000006239 protecting group Chemical group 0.000 description 2
• ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
• 238000003127 radioimmunoassay Methods 0.000 description 2
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
• 210000000844 retinal pigment epithelial cell Anatomy 0.000 description 2
• 210000003705 ribosome Anatomy 0.000 description 2
• 102200077327 rs104894832 Human genes 0.000 description 2
• 102220233125 rs1085307708 Human genes 0.000 description 2
• 102220023973 rs112534524 Human genes 0.000 description 2
• 102200031614 rs121964912 Human genes 0.000 description 2
• 102220251971 rs1368217140 Human genes 0.000 description 2
• 102220007192 rs146646971 Human genes 0.000 description 2
• 102200031815 rs149474608 Human genes 0.000 description 2
• 102220248709 rs1555729589 Human genes 0.000 description 2
• 102220082649 rs200472799 Human genes 0.000 description 2
• 102220065398 rs201431982 Human genes 0.000 description 2
• 102220145658 rs41278047 Human genes 0.000 description 2
• 102200158845 rs41475844 Human genes 0.000 description 2
• 102220045308 rs587781997 Human genes 0.000 description 2
• 102220045971 rs587782527 Human genes 0.000 description 2
• 102220142784 rs754572081 Human genes 0.000 description 2
• 102220142791 rs754972981 Human genes 0.000 description 2
• 102220276729 rs786202366 Human genes 0.000 description 2
• 102220075154 rs796052262 Human genes 0.000 description 2
• 102200007327 rs886041246 Human genes 0.000 description 2
• 239000000523 sample Substances 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 238000001542 size-exclusion chromatography Methods 0.000 description 2
• 239000004055 small Interfering RNA Substances 0.000 description 2
• FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
• 229940048086 sodium pyrophosphate Drugs 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 238000004659 sterilization and disinfection Methods 0.000 description 2
• 239000003206 sterilizing agent Substances 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 235000019818 tetrasodium diphosphate Nutrition 0.000 description 2
• 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
• 231100000167 toxic agent Toxicity 0.000 description 2
• 239000003440 toxic substance Substances 0.000 description 2
• KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
• 230000005026 transcription initiation Effects 0.000 description 2
• 238000010361 transduction Methods 0.000 description 2
• 230000026683 transduction Effects 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 241000701447 unidentified baculovirus Species 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 235000013343 vitamin Nutrition 0.000 description 2
• 239000011782 vitamin Substances 0.000 description 2
• 229940088594 vitamin Drugs 0.000 description 2
• 229930003231 vitamin Natural products 0.000 description 2
• GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
• VEVRNHHLCPGNDU-MUGJNUQGSA-N (2s)-2-amino-5-[1-[(5s)-5-amino-5-carboxypentyl]-3,5-bis[(3s)-3-amino-3-carboxypropyl]pyridin-1-ium-4-yl]pentanoate Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C([O-])=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-N 0.000 description 1
• JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
• CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
• NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
• BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• OYIFNHCXNCRBQI-UHFFFAOYSA-N 2-aminoadipic acid Chemical compound OC(=O)C(N)CCCC(O)=O OYIFNHCXNCRBQI-UHFFFAOYSA-N 0.000 description 1
• RDFMDVXONNIGBC-UHFFFAOYSA-N 2-aminoheptanoic acid Chemical compound CCCCCC(N)C(O)=O RDFMDVXONNIGBC-UHFFFAOYSA-N 0.000 description 1
• JUQLUIFNNFIIKC-UHFFFAOYSA-N 2-aminopimelic acid Chemical compound OC(=O)C(N)CCCCC(O)=O JUQLUIFNNFIIKC-UHFFFAOYSA-N 0.000 description 1
• BRMWTNUJHUMWMS-UHFFFAOYSA-N 3-Methylhistidine Natural products CN1C=NC(CC(N)C(O)=O)=C1 BRMWTNUJHUMWMS-UHFFFAOYSA-N 0.000 description 1
• PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 description 1
• VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
• 229940117976 5-hydroxylysine Drugs 0.000 description 1
• 208000036443 AIPL1-related retinopathy Diseases 0.000 description 1
• 101150016901 ALB1 gene Proteins 0.000 description 1
• 208000035657 Abasia Diseases 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 208000010370 Adenoviridae Infections Diseases 0.000 description 1
• 206010060931 Adenovirus infection Diseases 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 108020005544 Antisense RNA Proteins 0.000 description 1
• 101100274294 Arabidopsis thaliana CHLD gene Proteins 0.000 description 1
• 101100365087 Arabidopsis thaliana SCRA gene Proteins 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 201000001321 Bardet-Biedl syndrome Diseases 0.000 description 1
• 208000037663 Best vitelliform macular dystrophy Diseases 0.000 description 1
• 102100022794 Bestrophin-1 Human genes 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 208000019838 Blood disease Diseases 0.000 description 1
• ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000282832 Camelidae Species 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
• 206010060823 Choroidal neovascularisation Diseases 0.000 description 1
• 108700010070 Codon Usage Proteins 0.000 description 1
• 208000006992 Color Vision Defects Diseases 0.000 description 1
• 102220580139 Complement factor H_C1043R_mutation Human genes 0.000 description 1
• 102220593375 Complement factor H_C630W_mutation Human genes 0.000 description 1
• 102220593359 Complement factor H_C673S_mutation Human genes 0.000 description 1
• 102220593331 Complement factor H_C915S_mutation Human genes 0.000 description 1
• 102220580098 Complement factor H_D1119G_mutation Human genes 0.000 description 1
• 102220580055 Complement factor H_E1198A_mutation Human genes 0.000 description 1
• 102220580058 Complement factor H_F1199S_mutation Human genes 0.000 description 1
• 102220580130 Complement factor H_G1194D_mutation Human genes 0.000 description 1
• 102220593333 Complement factor H_H893R_mutation Human genes 0.000 description 1
• 102220593290 Complement factor H_N997T_mutation Human genes 0.000 description 1
• 102220580071 Complement factor H_P1226S_mutation Human genes 0.000 description 1
• 102220580092 Complement factor H_Q1076E_mutation Human genes 0.000 description 1
• 102220592797 Complement factor H_Q400K_mutation Human genes 0.000 description 1
• 102220580061 Complement factor H_R1215Q_mutation Human genes 0.000 description 1
• 102220592819 Complement factor H_R78G_mutation Human genes 0.000 description 1
• 102220580126 Complement factor H_T1184R_mutation Human genes 0.000 description 1
• 102220580099 Complement factor H_V1134G_mutation Human genes 0.000 description 1
• 102220580120 Complement factor H_W1157R_mutation Human genes 0.000 description 1
• 102220580105 Complement factor H_W1183C_mutation Human genes 0.000 description 1
• 102220580127 Complement factor H_W1183R_mutation Human genes 0.000 description 1
• 102220580141 Complement factor H_Y1021F_mutation Human genes 0.000 description 1
• 102220580100 Complement factor H_Y1142D_mutation Human genes 0.000 description 1
• 102220579974 Complement factor I_T300A_mutation Human genes 0.000 description 1
• 206010018325 Congenital glaucomas Diseases 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 102220597258 DNA helicase MCM8_Y42F_mutation Human genes 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108010053770 Deoxyribonucleases Proteins 0.000 description 1
• 102000016911 Deoxyribonucleases Human genes 0.000 description 1
• 206010012565 Developmental glaucoma Diseases 0.000 description 1
• 108090000204 Dipeptidase 1 Proteins 0.000 description 1
• 101100118093 Drosophila melanogaster eEF1alpha2 gene Proteins 0.000 description 1
• 101100456896 Drosophila melanogaster metl gene Proteins 0.000 description 1
• 102100023196 E3 ubiquitin-protein ligase MARCHF8 Human genes 0.000 description 1
• 101710190174 E3 ubiquitin-protein ligase MYLIP Proteins 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 1
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 1
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
• 208000012473 Goldmann-Favre syndrome Diseases 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 102220545750 HLA class II histocompatibility antigen, DQ alpha 1 chain_L74F_mutation Human genes 0.000 description 1
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
• 208000032087 Hereditary Leber Optic Atrophy Diseases 0.000 description 1
• 101000903449 Homo sapiens Bestrophin-1 Proteins 0.000 description 1
• 101001065295 Homo sapiens Fas-binding factor 1 Proteins 0.000 description 1
• 101001031607 Homo sapiens Four and a half LIM domains protein 1 Proteins 0.000 description 1
• 101000887490 Homo sapiens Guanine nucleotide-binding protein G(z) subunit alpha Proteins 0.000 description 1
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
• 101000997017 Homo sapiens Neural retina-specific leucine zipper protein Proteins 0.000 description 1
• 101000594760 Homo sapiens Nucleoredoxin-like protein 2 Proteins 0.000 description 1
• 101000741544 Homo sapiens Properdin Proteins 0.000 description 1
• 101000829506 Homo sapiens Rhodopsin kinase GRK1 Proteins 0.000 description 1
• 101100264173 Homo sapiens XIAP gene Proteins 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• AGPKZVBTJJNPAG-UHNVWZDZSA-N L-allo-Isoleucine Chemical compound CC[C@@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-UHNVWZDZSA-N 0.000 description 1
• RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
• 206010056715 Laurence-Moon-Bardet-Biedl syndrome Diseases 0.000 description 1
• 201000000639 Leber hereditary optic neuropathy Diseases 0.000 description 1
• NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
• 208000015439 Lysosomal storage disease Diseases 0.000 description 1
• 241000282567 Macaca fascicularis Species 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 102220494360 Methylmalonyl-CoA mutase, mitochondrial_G45D_mutation Human genes 0.000 description 1
• 241000713869 Moloney murine leukemia virus Species 0.000 description 1
• 101100434646 Mus musculus Alb gene Proteins 0.000 description 1
• DTERQYGMUDWYAZ-ZETCQYMHSA-N N(6)-acetyl-L-lysine Chemical compound CC(=O)NCCCC[C@H]([NH3+])C([O-])=O DTERQYGMUDWYAZ-ZETCQYMHSA-N 0.000 description 1
• JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 1
• JJIHLJJYMXLCOY-BYPYZUCNSA-N N-acetyl-L-serine Chemical compound CC(=O)N[C@@H](CO)C(O)=O JJIHLJJYMXLCOY-BYPYZUCNSA-N 0.000 description 1
• YPIGGYHFMKJNKV-UHFFFAOYSA-N N-ethylglycine Chemical compound CC[NH2+]CC([O-])=O YPIGGYHFMKJNKV-UHFFFAOYSA-N 0.000 description 1
• 108010065338 N-ethylglycine Proteins 0.000 description 1
• PYUSHNKNPOHWEZ-YFKPBYRVSA-N N-formyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC=O PYUSHNKNPOHWEZ-YFKPBYRVSA-N 0.000 description 1
• AKCRVYNORCOYQT-YFKPBYRVSA-N N-methyl-L-valine Chemical compound CN[C@@H](C(C)C)C(O)=O AKCRVYNORCOYQT-YFKPBYRVSA-N 0.000 description 1
• RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 102000007072 Nerve Growth Factors Human genes 0.000 description 1
• 102100034268 Neural retina-specific leucine zipper protein Human genes 0.000 description 1
• 208000001140 Night Blindness Diseases 0.000 description 1
• 102220594352 NmrA-like family domain-containing protein 1_T23I_mutation Human genes 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 108020004485 Nonsense Codon Proteins 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 101710106007 Nucleoredoxin-like protein 2 Proteins 0.000 description 1
• 201000007908 Ocular Albinism Diseases 0.000 description 1
• 102220466461 Olfactory receptor 13C9_T91S_mutation Human genes 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 208000034247 Pattern dystrophy Diseases 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 102100040375 Peripherin-2 Human genes 0.000 description 1
• 101710135995 Peripherin-2 Proteins 0.000 description 1
• 208000020547 Peroxisomal disease Diseases 0.000 description 1
• ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 102220473413 Photoreceptor ankyrin repeat protein_I49V_mutation Human genes 0.000 description 1
• 102100029533 Photoreceptor-specific nuclear receptor Human genes 0.000 description 1
• 101710164507 Photoreceptor-specific nuclear receptor Proteins 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 229920000153 Povidone-iodine Polymers 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 description 1
• 102220472076 Protein ENL_E167Q_mutation Human genes 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
• 108091030071 RNAI Proteins 0.000 description 1
• 238000011529 RT qPCR Methods 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 208000004453 Retinal Dysplasia Diseases 0.000 description 1
• 206010038933 Retinopathy of prematurity Diseases 0.000 description 1
• 206010038935 Retinopathy sickle cell Diseases 0.000 description 1
• 102100040756 Rhodopsin Human genes 0.000 description 1
• 108090000820 Rhodopsin Proteins 0.000 description 1
• 102100023742 Rhodopsin kinase GRK1 Human genes 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 102000005801 Rod Opsins Human genes 0.000 description 1
• 108010005063 Rod Opsins Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 101150105073 SCR1 gene Proteins 0.000 description 1
• 101100134054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) NTG1 gene Proteins 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• 102220590625 Spindlin-1_P26S_mutation Human genes 0.000 description 1
• 208000027073 Stargardt disease Diseases 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000006612 Transducin Human genes 0.000 description 1
• 108010087042 Transducin Proteins 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 208000014769 Usher Syndromes Diseases 0.000 description 1
• 108091034131 VA RNA Proteins 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 229930003268 Vitamin C Natural products 0.000 description 1
• 229930003427 Vitamin E Natural products 0.000 description 1
• JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
• QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 201000000761 achromatopsia Diseases 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 125000002015 acyclic group Chemical group 0.000 description 1
• 230000003044 adaptive effect Effects 0.000 description 1
• 208000011589 adenoviridae infectious disease Diseases 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 108010081667 aflibercept Proteins 0.000 description 1
• 229960002833 aflibercept Drugs 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 239000002168 alkylating agent Substances 0.000 description 1
• JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• 230000001668 ameliorated effect Effects 0.000 description 1
• 229940059260 amidate Drugs 0.000 description 1
• 150000001412 amines Chemical group 0.000 description 1
• 229940124277 aminobutyric acid Drugs 0.000 description 1
• 208000007502 anemia Diseases 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000006909 anti-apoptosis Effects 0.000 description 1
• 230000003466 anti-cipated effect Effects 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 229910052586 apatite Inorganic materials 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
• 210000004507 artificial chromosome Anatomy 0.000 description 1
• 239000003855 balanced salt solution Substances 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• 229940000635 beta-alanine Drugs 0.000 description 1
• 102000006635 beta-lactamase Human genes 0.000 description 1
• 229960000397 bevacizumab Drugs 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 231100001015 blood dyscrasias Toxicity 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 102220370497 c.1110G>A Human genes 0.000 description 1
• 102220368611 c.1291G>T Human genes 0.000 description 1
• 102220364547 c.1361A>C Human genes 0.000 description 1
• 102220411420 c.1532C>T Human genes 0.000 description 1
• 102200104120 c.1534G>A Human genes 0.000 description 1
• 102220398119 c.205A>G Human genes 0.000 description 1
• 102220383954 c.209A>C Human genes 0.000 description 1
• 102220411390 c.2461C>T Human genes 0.000 description 1
• 102220370219 c.2497G>A Human genes 0.000 description 1
• 102220357508 c.2557T>C Human genes 0.000 description 1
• 102220406162 c.3010A>G Human genes 0.000 description 1
• 102220414432 c.3680C>T Human genes 0.000 description 1
• 102200149728 c.386G>A Human genes 0.000 description 1
• 102220405930 c.41C>T Human genes 0.000 description 1
• 102220380905 c.559C>T Human genes 0.000 description 1
• 102220370492 c.65A>G Human genes 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 125000004432 carbon atom Chemical group C* 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 238000002659 cell therapy Methods 0.000 description 1
• 230000007248 cellular mechanism Effects 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 229960002173 citrulline Drugs 0.000 description 1
• 235000013477 citrulline Nutrition 0.000 description 1
• 238000005352 clarification Methods 0.000 description 1
• 239000008395 clarifying agent Substances 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 230000004186 co-expression Effects 0.000 description 1
• 201000007254 color blindness Diseases 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 210000005130 cone cell inner segment Anatomy 0.000 description 1
• 208000006623 congenital stationary night blindness Diseases 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 229940108928 copper Drugs 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 125000000392 cycloalkenyl group Chemical group 0.000 description 1
• 125000000753 cycloalkyl group Chemical group 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000003412 degenerative effect Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
• 210000001787 dendrite Anatomy 0.000 description 1
• 238000000326 densiometry Methods 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 238000009795 derivation Methods 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 229950006137 dexfosfoserine Drugs 0.000 description 1
• 229960000633 dextran sulfate Drugs 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
• 201000003441 enhanced S-cone syndrome Diseases 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 238000006911 enzymatic reaction Methods 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
• NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
• 210000000609 ganglia Anatomy 0.000 description 1
• 238000001476 gene delivery Methods 0.000 description 1
• 238000003197 gene knockdown Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 229960001031 glucose Drugs 0.000 description 1
• 235000001727 glucose Nutrition 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 239000000185 hemagglutinin Substances 0.000 description 1
• 208000014951 hematologic disease Diseases 0.000 description 1
• 208000018706 hematopoietic system disease Diseases 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 239000012510 hollow fiber Substances 0.000 description 1
• 102000057125 human FHL1 Human genes 0.000 description 1
• 102000052301 human GNAZ Human genes 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• 208000000069 hyperpigmentation Diseases 0.000 description 1
• 230000003810 hyperpigmentation Effects 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 238000010324 immunological assay Methods 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 108010048996 interstitial retinol-binding protein Proteins 0.000 description 1
• 210000005061 intracellular organelle Anatomy 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
• 238000001738 isopycnic centrifugation Methods 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 235000015110 jellies Nutrition 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 238000002430 laser surgery Methods 0.000 description 1
• 229960004194 lidocaine Drugs 0.000 description 1
• 230000004446 light reflex Effects 0.000 description 1
• 230000029226 lipidation Effects 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 208000018769 loss of vision Diseases 0.000 description 1
• 231100000864 loss of vision Toxicity 0.000 description 1
• 235000012680 lutein Nutrition 0.000 description 1
• 229960005375 lutein Drugs 0.000 description 1
• KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
• 239000001656 lutein Substances 0.000 description 1
• ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 210000003712 lysosome Anatomy 0.000 description 1
• 230000001868 lysosomic effect Effects 0.000 description 1
• 150000002671 lyxoses Chemical class 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
• 108091070501 miRNA Proteins 0.000 description 1
• 239000002679 microRNA Substances 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 210000003470 mitochondria Anatomy 0.000 description 1
• 230000037230 mobility Effects 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 239000002637 mydriatic agent Substances 0.000 description 1
• 238000001728 nano-filtration Methods 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 210000005044 neurofilament Anatomy 0.000 description 1
• 239000003900 neurotrophic factor Substances 0.000 description 1
• 239000003076 neurotropic agent Substances 0.000 description 1
• 230000004297 night vision Effects 0.000 description 1
• 230000037434 nonsense mutation Effects 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 201000005111 ocular hyperemia Diseases 0.000 description 1
• 210000002597 off-bipolar cell Anatomy 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
• 229940012843 omega-3 fatty acid Drugs 0.000 description 1
• 239000006014 omega-3 oil Substances 0.000 description 1
• 229940033080 omega-6 fatty acid Drugs 0.000 description 1
• 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
• 210000001743 on-bipolar cell Anatomy 0.000 description 1
• 210000001328 optic nerve Anatomy 0.000 description 1
• 230000004466 optokinetic reflex Effects 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
• YVBBRRALBYAZBM-UHFFFAOYSA-N perfluorooctane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YVBBRRALBYAZBM-UHFFFAOYSA-N 0.000 description 1
• 239000003208 petroleum Substances 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 230000000649 photocoagulation Effects 0.000 description 1
• 238000002428 photodynamic therapy Methods 0.000 description 1
• 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 102000054765 polymorphisms of proteins Human genes 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 229920000136 polysorbate Polymers 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 229960001621 povidone-iodine Drugs 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 229960003981 proparacaine Drugs 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 238000002331 protein detection Methods 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 229960003876 ranibizumab Drugs 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 208000004644 retinal vein occlusion Diseases 0.000 description 1
• 201000007714 retinoschisis Diseases 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108020004418 ribosomal RNA Proteins 0.000 description 1
• 210000005078 rod cell inner segment Anatomy 0.000 description 1
• 102200060767 rs1042579 Human genes 0.000 description 1
• 102200080792 rs104894867 Human genes 0.000 description 1
• 102220132395 rs1057515456 Human genes 0.000 description 1
• 102220205166 rs1057521973 Human genes 0.000 description 1
• 102220230310 rs1064794367 Human genes 0.000 description 1
• 102200031812 rs1065489 Human genes 0.000 description 1
• 102200033400 rs1085307884 Human genes 0.000 description 1
• 102200007576 rs1085308006 Human genes 0.000 description 1
• 102200070289 rs111033632 Human genes 0.000 description 1
• 102220235162 rs1131691304 Human genes 0.000 description 1
• 102220236470 rs1131692200 Human genes 0.000 description 1
• 102220145667 rs113273712 Human genes 0.000 description 1
• 102200031964 rs11539862 Human genes 0.000 description 1
• 102220085522 rs116953461 Human genes 0.000 description 1
• 102200074171 rs119491109 Human genes 0.000 description 1
• 102200162588 rs121434443 Human genes 0.000 description 1
• 102200071739 rs121908097 Human genes 0.000 description 1
• 102200067248 rs121912617 Human genes 0.000 description 1
• 102220131076 rs121913051 Human genes 0.000 description 1
• 102200031708 rs121913051 Human genes 0.000 description 1
• 102200031822 rs121913052 Human genes 0.000 description 1
• 102200031961 rs121913053 Human genes 0.000 description 1
• 102200031972 rs121913055 Human genes 0.000 description 1
• 102200031829 rs121913056 Human genes 0.000 description 1
• 102200072281 rs121917935 Human genes 0.000 description 1
• 102220004301 rs121964913 Human genes 0.000 description 1
• 102200031612 rs121964918 Human genes 0.000 description 1
• 102200005650 rs137852390 Human genes 0.000 description 1
• 102200090503 rs137852484 Human genes 0.000 description 1
• 102200028038 rs137852956 Human genes 0.000 description 1
• 102200060279 rs137853103 Human genes 0.000 description 1
• 102220266874 rs140528613 Human genes 0.000 description 1
• 102220033771 rs140602973 Human genes 0.000 description 1
• 102220277606 rs1415062077 Human genes 0.000 description 1
• 102220260558 rs1424659316 Human genes 0.000 description 1
• 102200005391 rs142761835 Human genes 0.000 description 1
• 102200031959 rs145975787 Human genes 0.000 description 1
• 102220130097 rs147403664 Human genes 0.000 description 1
• 102220036370 rs147863331 Human genes 0.000 description 1
• 102220058557 rs148269839 Human genes 0.000 description 1
• 102220296115 rs1554417370 Human genes 0.000 description 1
• 102220245036 rs1555800701 Human genes 0.000 description 1
• 102220275877 rs1555899881 Human genes 0.000 description 1
• 102220333231 rs1555900746 Human genes 0.000 description 1
• 102200031954 rs15809 Human genes 0.000 description 1
• 102200111347 rs179363868 Human genes 0.000 description 1
• 102220130925 rs186711438 Human genes 0.000 description 1
• 102220050657 rs193920819 Human genes 0.000 description 1
• 102220009010 rs193922571 Human genes 0.000 description 1
• 102220024724 rs199472768 Human genes 0.000 description 1
• 102200097257 rs199472847 Human genes 0.000 description 1
• 102200108951 rs199473098 Human genes 0.000 description 1
• 102200027755 rs199475651 Human genes 0.000 description 1
• 102220311343 rs200419722 Human genes 0.000 description 1
• 102220243175 rs200973120 Human genes 0.000 description 1
• 102220131056 rs201411537 Human genes 0.000 description 1
• 102220130926 rs201816520 Human genes 0.000 description 1
• 102200132076 rs2241880 Human genes 0.000 description 1
• 102220024310 rs267607437 Human genes 0.000 description 1
• 102200060108 rs28363283 Human genes 0.000 description 1
• 102200038249 rs28942079 Human genes 0.000 description 1
• 102200082882 rs33936254 Human genes 0.000 description 1
• 102200082873 rs33946157 Human genes 0.000 description 1
• 102220005152 rs34439278 Human genes 0.000 description 1
• 102200031949 rs35274867 Human genes 0.000 description 1
• 102200031948 rs35343172 Human genes 0.000 description 1
• 102200031825 rs35453854 Human genes 0.000 description 1
• 102220095556 rs370602633 Human genes 0.000 description 1
• 102220103421 rs371045201 Human genes 0.000 description 1
• 102220114426 rs376102257 Human genes 0.000 description 1
• 102200018971 rs386834233 Human genes 0.000 description 1
• 102200037690 rs387906303 Human genes 0.000 description 1
• 102220018594 rs397515447 Human genes 0.000 description 1
• 102220011966 rs397515734 Human genes 0.000 description 1
• 102220012015 rs397515767 Human genes 0.000 description 1
• 102220014288 rs397517019 Human genes 0.000 description 1
• 102220028922 rs398123320 Human genes 0.000 description 1
• 102220061855 rs41293445 Human genes 0.000 description 1
• 102200009692 rs4149584 Human genes 0.000 description 1
• 102220018481 rs45462194 Human genes 0.000 description 1
• 102200031973 rs460184 Human genes 0.000 description 1
• 102200031971 rs460897 Human genes 0.000 description 1
• 102200152570 rs483352923 Human genes 0.000 description 1
• 102200031821 rs515299 Human genes 0.000 description 1
• 102200018271 rs515726205 Human genes 0.000 description 1
• 102220102189 rs528218090 Human genes 0.000 description 1
• 102200031965 rs534399 Human genes 0.000 description 1
• 102220130937 rs55771831 Human genes 0.000 description 1
• 102220130922 rs55807605 Human genes 0.000 description 1
• 102220040558 rs560052209 Human genes 0.000 description 1
• 102220041131 rs560967532 Human genes 0.000 description 1
• 102220024438 rs57422427 Human genes 0.000 description 1
• 102220093838 rs587778534 Human genes 0.000 description 1
• 102220032995 rs61750194 Human genes 0.000 description 1
• 102220046717 rs61754444 Human genes 0.000 description 1
• 102220021633 rs62625308 Human genes 0.000 description 1
• 102220058466 rs730882087 Human genes 0.000 description 1
• 102200037508 rs730882091 Human genes 0.000 description 1
• 102220058472 rs730882093 Human genes 0.000 description 1
• 102200107879 rs74315432 Human genes 0.000 description 1
• 102220142786 rs7437875 Human genes 0.000 description 1
• 102220069750 rs745894130 Human genes 0.000 description 1
• 102220236040 rs749855263 Human genes 0.000 description 1
• 102220092086 rs750354350 Human genes 0.000 description 1
• 102220090969 rs756143591 Human genes 0.000 description 1
• 102220097830 rs757411357 Human genes 0.000 description 1
• 102200038285 rs758194385 Human genes 0.000 description 1
• 102220277681 rs760158426 Human genes 0.000 description 1
• 102220225683 rs761872951 Human genes 0.000 description 1
• 102220144547 rs769438781 Human genes 0.000 description 1
• 102220098099 rs777112652 Human genes 0.000 description 1
• 102220278847 rs778998026 Human genes 0.000 description 1
• 102220129164 rs782298787 Human genes 0.000 description 1
• 102220061222 rs786201058 Human genes 0.000 description 1
• 102200055157 rs786205675 Human genes 0.000 description 1
• 102220074117 rs796051905 Human genes 0.000 description 1
• 102200031793 rs800292 Human genes 0.000 description 1
• 102220280443 rs80358540 Human genes 0.000 description 1
• 102220088967 rs869312689 Human genes 0.000 description 1
• 102220094514 rs876658325 Human genes 0.000 description 1
• 102220103011 rs878853872 Human genes 0.000 description 1
• 102200037655 rs879254589 Human genes 0.000 description 1
• 102220105622 rs879254669 Human genes 0.000 description 1
• 102220105716 rs879254746 Human genes 0.000 description 1
• 102220105855 rs879254852 Human genes 0.000 description 1
• 102220106888 rs886037849 Human genes 0.000 description 1
• 102220155295 rs886061561 Human genes 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 229940043230 sarcosine Drugs 0.000 description 1
• 238000013341 scale-up Methods 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 210000003786 sclera Anatomy 0.000 description 1
• 150000003341 sedoheptuloses Chemical class 0.000 description 1
• 108010079094 short-wavelength opsin Proteins 0.000 description 1
• 238000004904 shortening Methods 0.000 description 1
• 239000002924 silencing RNA Substances 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 239000012064 sodium phosphate buffer Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000013595 supernatant sample Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• YSMODUONRAFBET-WHFBIAKZSA-N threo-5-hydroxy-L-lysine Chemical compound NC[C@@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-WHFBIAKZSA-N 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 230000010415 tropism Effects 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 235000019154 vitamin C Nutrition 0.000 description 1
• 239000011718 vitamin C Substances 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 229940046009 vitamin E Drugs 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 150000003722 vitamin derivatives Chemical class 0.000 description 1
• 201000007790 vitelliform macular dystrophy Diseases 0.000 description 1
• 208000020938 vitelliform macular dystrophy 2 Diseases 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
• 150000003742 xyloses Chemical class 0.000 description 1
• 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
• 235000010930 zeaxanthin Nutrition 0.000 description 1
• 229940043269 zeaxanthin Drugs 0.000 description 1
• 239000001775 zeaxanthin Substances 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 235000016804 zinc Nutrition 0.000 description 1